NEIMETH — NEIMETH INTERNATIONAL PHARMACEUTICALS Disclosures
5 filings on the Nigerian Exchange Group.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) is listed on the Nigerian Exchange Group (NGX). This page tracks every regulatory disclosure NEIMETH INTERNATIONAL PHARMACEUTICALS has filed with the exchange — covering board-meeting notices and director dealings — with plain-English summaries and direct links to each official PDF. The most recent filing was on 14 Jul 2026, and the records here go back to 1 Jul 2026. NEIMETH INTERNATIONAL PHARMACEUTICALS has a market capitalisation of about ₦34.61B and currently carries a HOLD signal on Aboki Forex's fundamental model.
NEIMETH Stock Snapshot
HOLD · 51.5/100Market Cap
₦34.61B
P/E Ratio
35.20
EPS (₦)
0.23
ROE %
35.80
Div Yield %
—
P/B Ratio
12.60
Latest NEIMETH filings
Board Meeting 14 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- NOTICES OF BOARD MEETING (BM) - NOTICE
* Neimeth International Pharmaceuticals Plc has scheduled a board meeting for July 24, 2026, to review and approve its unaudited financial statements for the second quarter of 2026.
* A closed period for trading in the company’s securities commenced on July 1, 2026, and will remain in effect until 24 hours after the Q2 financial results are released to the public.
📄 View PDF
Director Dealing 3 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Clinoscope Services Limited, a substantial shareholder of Neimeth International Pharmaceuticals Plc, purchased 63,553,172 ordinary shares of the company.
* The transaction took place on June 30, 2026, at a price of ₦7.79 per share.
📄 View PDF
Director Dealing 1 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Non-Executive Director Eric Okoruwa purchased 1,606,766 ordinary shares of Neimeth International Pharmaceuticals Plc.
* The shares were acquired at a price of ₦8.50 per unit on June 23, 2026.
📄 View PDF
Director Dealing 1 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Clinoscope Services Limited, a substantial shareholder, acquired 100,000,000 ordinary shares of Neimeth International Pharmaceuticals Plc.
* The share purchase transactions took place between June 15 and June 19, 2026, in Lagos.
* The acquisition was executed at varying price points, resulting in an average purchase price of ₦9.41 per share.
📄 View PDF
Director Dealing 1 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Clinoscope Services Limited, a substantial shareholder of Neimeth International Pharmaceuticals Plc., has disclosed the sale of its shares.
* The transaction involved the sale of 20,000,000 ordinary shares at a price of ₦11.00 per share.
* The sale took place in Lagos on June 3, 2026.
📄 View PDF
What these NEIMETH disclosures mean
Board Meeting
Notice that NEIMETH INTERNATIONAL PHARMACEUTICALS's board of directors is meeting to consider results, dividends or other corporate matters. Board-meeting notices often precede a financial results release.
Director Dealing
Disclosure of purchases or sales of NEIMETH shares by the company's directors and other insiders, as required by Nigerian Exchange rules.
NEIMETH disclosures — frequently asked questions
NEIMETH INTERNATIONAL PHARMACEUTICALS has 5 recent disclosures on record on the Nigerian Exchange Group, covering board-meeting notices and director dealings. The most recent was filed on 14 Jul 2026. Each filing on this page links to the official PDF on the NGX document library.
Every NEIMETH disclosure on this page links directly to the official PDF published on the Nigerian Exchange (NGX) document library. You can also get push notifications the moment NEIMETH INTERNATIONAL PHARMACEUTICALS files a new disclosure by using the Aboki Forex app.
Based on Aboki Forex's fundamental model, NEIMETH currently carries a HOLD signal with a fundamental score of 51.5/100, a P/E ratio of 35.20 and a return on equity of 35.80%. This is not investment advice — review the full fundamentals and the latest disclosures before deciding.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) has a market capitalisation of approximately ₦34.61B on the Nigerian Exchange Group.
NGX-listed companies like NEIMETH INTERNATIONAL PHARMACEUTICALS file disclosures whenever there is a material event — typically quarterly and annual financial results, plus board meetings, AGM notices, dividend declarations and director dealings as they happen. This page is rebuilt regularly so the latest NEIMETH filings always appear at the top.